Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

SHA:601607 Revenue

Shanghai Pharmaceuticals Holding had revenue of 75.26B CNY in the quarter ending March 31, 2026, with 6.36% growth. This brings the company's revenue in the last twelve months to 288.08B, up 4.43% year-over-year. In the year 2025, Shanghai Pharmaceuticals Holding had annual revenue of 283.58B with 3.03% growth.

• Revenue (ttm): 288.08B
• Revenue Growth: +4.43%
• P/S Ratio: 0.20
• Revenue / Employee: 5.81M
• Employees: 49,608
• Market Cap: 57.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	283.58B	8.33B	3.03%
Dec 31, 2024	275.25B	14.96B	5.75%
Dec 31, 2023	260.30B	28.31B	12.21%
Dec 31, 2022	231.98B	16.16B	7.49%
Dec 31, 2021	215.82B	23.92B	12.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 6, 2026

Data Sources Report a data error